宫颈癌临床病理诊断技术研究进展
Clinicopathological diagnosis and research progress of cervical cancer
张斌 1孙丹丹 1经晶 1范例1
作者信息
- 1. 吉林金域医学检验所有限公司,长春 130000
- 折叠
摘要
宫颈癌为女性生殖系统最常见恶性肿瘤,临床早期针对宫颈癌或疑似患者的病理诊断方式诸多.近些年随着检验领域蓬勃发展,免疫组化病理诊断技术、分子病理诊断技术、RNA原位杂交(RNA Scope)技术的出现为宫颈癌临床病理诊断工作开展带来了新方向.本研究概述了宫颈癌流行病学展示该疾病发病现状,并分析多种病理诊断技术的临床应用,分别探讨了不同病理诊断技术的优缺点.同时从宏观角度出发,探究宫颈癌临床病理诊断工作未来发展趋势.以此为宫颈癌风险预测模型及病理诊断体系框架建立提供重要数据支持,采取最佳病理诊断技术分析患者潜在风险或病理分型.最终满足患者群体个性化诊治需求,凸显其高质量医疗服务水平.
Abstract
Cervical cancer is the most common malignant tumor of female reproductive system.There are many pathologic diagnosis methods for cervical cancer or suspected patients in early clinical stage..In recent years,with the vigorous development of the field of examination,the emergence of immunohistochemical pathological diagnosis technology,molecular pathological diagnosis technology,and RNA in situ hybridization(RNA Scope)technology has brought new directions for the clinicopathological diagnosis of cervical cancer.By summarizing the epidemiology of cervical cancer,this study showed the current situation of the disease,analyzed the clinical application of various pathological diagnostic techniques,and discussed the advantages and disadvantages of different pathological diagnostic techniques.At the same time,the future development trend of clinicopathological diagnosis of cervical cancer was explored from a macroscopic point of view.This provides important data support for the establishment of cervical cancer risk prediction model and pathological diagnosis system framework,and adopts the best pathological diagnosis technology to analyze the potential risk or pathological classification of patients.Finally,it can meet the personalized diagnosis and treatment needs of patient groups and highlight its high-quality medical service level.
关键词
宫颈癌/液基细胞学/荧光原位杂交/高通量测序Key words
cervical cancer/liquid-based cytology/fluorescence in situ hybridization/high-throughput sequencing引用本文复制引用
出版年
2024
NETL
NSTL
万方数据